HeartBeam (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care through personalized insights, received FDA 510(k) clearance for its 12-lead ECG synthesis software for ...
TipRanks on MSN
HeartBeam (NASDAQ: BEAT) secures FDA 510(k) clearance for 12-lead ECG synthesis software following successful appeal
Austin, Texas, United States, December 10th, 2025, FinanceWire HeartBeam (NASDAQ: BEAT), a medical technology company focused ...
Abstract: Atrial fibrillation (A-Fib), a common cardiac arrhythmia, is linked to serious complications like heart failure and stroke, which early diagnosis could prevent. However, its paroxysmal and ...
Tribune Content Agency on MSN
Ask the doctors: Stroke likely not caused by medication, but worth reporting
After getting a pacemaker, my 90- year-old mother was diagnosed with A-fib. She resisted taking a blood thinner for stroke risk but finally agreed. Not 90 minutes after the first pill, she had a major ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results